These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


520 related items for PubMed ID: 22917983

  • 1. Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: a review of controlled and naturalistic studies.
    Fredriksen M, Halmøy A, Faraone SV, Haavik J.
    Eur Neuropsychopharmacol; 2013 Jun; 23(6):508-27. PubMed ID: 22917983
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults.
    Santosh PJ, Sattar S, Canagaratnam M.
    CNS Drugs; 2011 Sep 01; 25(9):737-63. PubMed ID: 21870887
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A systematic review of combination therapy with stimulants and atomoxetine for attention-deficit/hyperactivity disorder, including patient characteristics, treatment strategies, effectiveness, and tolerability.
    Treuer T, Gau SS, Méndez L, Montgomery W, Monk JA, Altin M, Wu S, Lin CC, Dueñas HJ.
    J Child Adolesc Psychopharmacol; 2013 Apr 01; 23(3):179-93. PubMed ID: 23560600
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis.
    Peterson K, McDonagh MS, Fu R.
    Psychopharmacology (Berl); 2008 Mar 01; 197(1):1-11. PubMed ID: 18026719
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacological treatment of attention-deficit/hyperactivity disorder in adults.
    Slatkoff J, Greenfield B.
    Expert Opin Investig Drugs; 2006 Jun 01; 15(6):649-67. PubMed ID: 16732717
    [Abstract] [Full Text] [Related]

  • 17. Treatment of attention-deficit/hyperactivity disorder.
    Jadad AR, Boyle M, Cunningham C, Kim M, Schachar R.
    Evid Rep Technol Assess (Summ); 1999 Nov 01; (11):i-viii, 1-341. PubMed ID: 10790990
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Improving decision making in the treatment of ADHD.
    Vitiello B.
    Am J Psychiatry; 2008 Jun 01; 165(6):666-7. PubMed ID: 18519529
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.